CN Patent

CN115919866A — 特泊替尼固体分散体及其制备方法

Assigned to Shenzhen Neptunus Pharmaceutical Research Institute Co Ltd · Expires 2023-04-07 · 3y expired

What this patent protects

本发明提供了一种特泊替尼固体分散体，该组合物包含水溶性聚合物载体和特泊替尼，二者的所占质量比为5:1～20:1。本发明提供的特泊替尼固体分散体在常温状态下稳定存在，制备过程中工艺参数可控，制备过程简单，能够显著提高特泊替尼的溶解度、改善生物利用度。本发明还提供了一种该特泊替尼固体分散体的制备方法。

USPTO Abstract

本发明提供了一种特泊替尼固体分散体，该组合物包含水溶性聚合物载体和特泊替尼，二者的所占质量比为5:1～20:1。本发明提供的特泊替尼固体分散体在常温状态下稳定存在，制备过程中工艺参数可控，制备过程简单，能够显著提高特泊替尼的溶解度、改善生物利用度。本发明还提供了一种该特泊替尼固体分散体的制备方法。

Drugs covered by this patent

Patent Metadata

Patent number
CN115919866A
Jurisdiction
CN
Classification
—
Expires
2023-04-07
Drug substance claim
No
Drug product claim
No
Assignee
Shenzhen Neptunus Pharmaceutical Research Institute Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.